DCAT Week LP 2024 DCAT Week LP 2024

Meet us at

Image 18-21st March, 2024
Location 125 E 50th St, New York, NY 10022

Suite 504 & 604 |The Benjamin Royal Sonesta Hotel

Speak to our Expert

By submittng this form you accept the Privacy Policy and Terms of Use of this website.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The Aurigene expertise

Aurigene Pharmaceutical Services is a leading contract research, development and manufacturing organization (CDMO) that provides a range of services. Built on the legacy of accelerating innovation and backed by a vast experience in integrated drug discovery, development and manufacturing services, we provide access to our knowledge, resources, capability and experience, creating shared success for our clients and ultimately patients.

About Us Image

About DCAT

Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain.            

For over 130 years, DCAT has been providing a lifelong collegial community for its member companies and their representatives. DCAT facilitates the development of relationships within its unique member company profile, which spans the whole manufacturing value chain of the Bio/Pharmaceutical industry.            

DCAT develops objective, expert-driven education programmes and informational services that help its member companies in getting quick insights into industry market trends, best practices, and industry-related concerns

Meet our Experts

We are excited to meet you and explore potential opportunities for collaboration and partnership. To schedule a meeting with us, simply provide us with your information and we will be in touch to arrange a time that works for you. We are excited to connect with you and explore how we can work together to drive success in the industry.

Akhil Rvi

Akhil Ravi

Chief Executive Officer

Reshmi Nair

Rashmi Nair

CDMO Head, North America

Image

Kapil Choudhury

Global Head - Business Development and Sales

Dr Roger Lias

Global Commercial Head – NBE

Nem Kaurin

Nem Kaurin

Director - Business Development

Abhishek Goel

Abhishek Goel

Director - Business Development

Services we Offer

Chemical Development Services

Aurigene Pharmaceutical Services provides a wide range of pharmaceutical drug development services for pre-clinical and clinical trials I, II and III wherein we synthesize New Chemical Entity (NCE) from few grams for efficacy and toxicology studies to multi-kilogram for clinical trial studies. These can be offered from GLP compliant and cGMP environment to meet client requirements.

Formulation Development Services

Aurigene Pharmaceutical Services offers end-to-end formulation development services ranging from early development to clinical supplies for new chemical entities for the pharmaceutical, nutraceutical & animal healthcare industry along with life cycle extension of the products. We have the expertise along with the state-of-the-art infrastructure and diverse experience to develop formulations for your pre-clinical and clinical needs to support oral, topical & parenteral administration. Our formulation development effort revolves around developing the best formulation for your compound, focusing on the desired bioavailability and optimal stability of your drug product.

Starting with comprehensive pre-formulation services Aurigene Pharmaceutical Services helps its clients to determine optimal dosage forms they can use for pre-clinical or clinical applications.

Manufacturing Services

Aurigene has access to the manufacturing facilities of Dr. Reddy’s and a network of strategic business partners. Our pharmaceutical drug manufacturing services offer a wide range of manufacturing services from a few kilos to multi tons of cGMP manufacturing of Key Starting Material (KSM) / Registered Starting Materials (RSM), advanced intermediates, APIs and finished formulations. We have manufacturing options across the globe, with our facilities located in India, the UK, Mexico and the US. With a strong legacy of supporting New Chemical Entity (NCE) manufacturing, drug substances and drug products commercial manufacturing, we are able to cater to Pharma, Specialty, Nutraceutical and Animal Health companies.

Why Aurigene Pharmaceutical Services?

Infrastructure 8 US FDA plants, 2 R&D centers and AAALAC animal vivarium

One Stop Shop Discovery to manufacturing

Science Strong technology platforms with niche/ sensitive/ complex chemistry expertise

Digitally Enabled Systems ELN, e-BPRs, MES, SAP etc. are fully enabled at R&D/cGMP site

ESG Commitment to highest standards of Environment, Social and Governance

CDMO Facility Locations

Hyderabad:

Aurigene Pharmaceutical Services Limited,            
Bollaram Road, Miyapur, Jaya Prakash Narayan Nagar, Miyapur, Telangana 500049

Bangalore:

Aurigene Pharmaceutical Services Limited,            
39-40 Hosur Road KIADB Industrial Area, Joggers Ln, Phase 2, Electronic City, Bengaluru, Karnataka 560100

Visakhapatnam:

APIIC Industrial Estate, Pydibhimavarama (village), Srikakulam district, Andhra Pradesh, India.

UK: API/ RSM Manufacturing Plant

Steanard Ln, Mirfield W14 8HZ, United Kingdom

Mexico:

C.P, Carretera Federal Cuernavaca-Cuautla Km. 4.5 Colonia CIVAC Jiutepec, 62578 Cuernavaca, Mor. Mexico

©2024 Aurigene Pharmaceutical Services Ltd. | All rights reserved.

logo
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack